Medigene AG: Medigene announces issuance and number of new shares to settle last Trianta milestone payment
The Executive Management Board of Medigene AG (FSE: MDG1, Prime Standard, TecDAX) with the approval of the Company's Sup…
The Executive Management Board of Medigene AG (FSE: MDG1, Prime Standard, TecDAX) with the approval of the Company's Sup…
Der Vorstand der Medigene AG (FWB: MDG1, Prime Standard, TecDAX) hat heute mit Zustimmung des Aufsichtsrats beschlossen,…
Growing revenues from core business immunotherapies, clinical trial application for second immunotherapy submitted, fina…
Die Medigene AG (FWB: MDG1, Prime Standard, TecDAX), ein Immunonkologie-Unternehmen mit klinischen Projekten fokussiert…
Medigene AG (MDG1, Frankfurt, Prime Standard), a clinical stage immune-oncology company, announced the treatment start o…
Das Immunonkologie-Unternehmen Medigene AG (MDG1, Frankfurt, Prime Standard) gibt bekannt, dass in ihrer klinischen Phas…
. Chief Scientific Officer Prof Dolores Schendel appointed new Chief Executive Officer of Medigene AG Dave Lemus appoi…
. Chief Scientific Officer Prof. Dr. Dolores Schendel wird neue Vorstandsvorsitzende der Medigene AG Dave Lemus wird C…
. - Shareholders approve all resolutions with a high majority - Creation of new Authorized Capital resolved Medigene AG…
Medigene AG (MDG1, Frankfurt, Prime Standard) announced today that the capital measure for the funding of its cancer imm…